-
2025-521381-10-00
Moderately to Severely Active Ulcerative Colitis 5 2025-12-03
-
2025-521242-26-00
Moderately to Severely Active Ulcerative Colitis 4 2025-11-27
-
2025-521947-19-00
Healthy, Hepatic Insufficiency 3 2025-11-19
-
2024-520219-42-00
ivosidenib maintenance after SOC adjuvant chemotherapy 10 2025-11-18
-
2025-522290-11-00
Cholangiocarcinoma, pancreatic cancer, colo-rectal canc 3 2025-11-18
-
2024-520029-35-01
ADVANCED BILIARY TRACT CARCINOMA 4 2025-11-17
-
2025-521227-70-00
Patients with locally advanced or metastatic prostate c 7 2025-11-13
-
2025-521273-14-00
Solid neoplasms of the digestive system (primary and/or 7 2025-11-10
-
2025-520690-39-00
Moderately to Severely Active Ulcerative Colitis (UC) 4 2025-11-04
-
2025-522915-40-00
Healthy volunteers, Impaired renal function and suspect 3 2025-10-28
-
2024-519495-83-00
Digestive system diseases 4 2025-10-28
-
2022-502770-16-00
GERD, Cows' milk allergy 11 2025-10-27
-
2024-517877-26-00
Pancreatic resection 10 2025-10-16
-
2024-518714-31-00
Erosive esophagitis (EE) due to gastroesophageal reflux 5 2025-10-03
-
2024-517330-18-00
advanced, non resectable or metastatic cholangio- or ga 4 2025-10-02
-
2023-510490-34-00
Patients with functionally resectable pancreatic ductal 4 2025-09-29
-
2025-521856-47-00
Bile acid diarrhoea 11 2025-09-29
-
2024-516804-40-00
Progressive Familial Intrahepatic Cholestasis 6 2025-09-25
-
2024-516099-13-00
Severe Irritable Bowel Syndrome (IBS) 5 2025-09-25
-
2024-520210-21-00
Crohn’s Disease 5 2025-09-19
-
2024-519782-21-00
Anal high-grade squamous intraepithelial lesions (HSIL) 6 2025-09-18
-
2024-511993-55-00
bile acid diarrhoea (BAD) 4 2025-09-18
-
2025-521158-40-00
oesophageal cancer 4 2025-09-12
-
2023-508500-38-00
Crohn's disease 4 2025-09-12